The study, designed to promote lymph flow and optimize body mass index (BMI) after breast cancer surgery, saw a 97% success rate for patients in the program one year after surgery. Viewed as one of the most unfortunate outcomes of breast cancer treatment, lymphedema is characterized by an accumulation of lymph fluid in the interstitial spaces of the affected limb, leading to chronic ipsilateral limb swelling causing psychosocial distress and physical challenges for patients. Continued at MedicalNewsToday>>
